GfK launches snapshot doc surveys

GfK launched a new product—Flashpoints—allowing marketers to survey 100 physicians in one week. 


The offering will provide a snapshot of physician behaviors or perceptions as they react to a market event or drug launch, for example. The customized survey allows for five close-ended questions, with the option of using open-ended questions for an additional charge, according to a GfK statement. "In circumstances where clients only require a topline market pulse on a given issue-of-the-moment—or when a decision needs to be made imminently—FlashPoints serves as an efficient way to gather reliable, representative and rapid feedback, said Maureen McLaughlin, chief marketing officer at GfK Healthcare, in the statement.


GfK is billing the service as the only one of its kind available. A spokesperson for IMS Health said IMS doesn't offer a comparable one-week survey, but can provide survey results for over 3,000 physicians on a quarterly basis for clients.

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.